Comment on: “Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively”
Author:
- 7 December 2021
- journal article
- letter
- Published by Springer Nature in CNS Drugs
- Vol. 36 (1) , 101-102
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and MetabolismMolecules, 2015
- Current Place of Monoamine Oxidase Inhibitors in the Treatment of DepressionCNS Drugs, 2013
- Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine OxidasesBiochemistry, 2009
- The therapeutic potential of monoamine oxidase inhibitorsNature Reviews Neuroscience, 2006
- Monoamine Oxidases: Certainties and UncertaintiesCurrent Medicinal Chemistry, 2004
- Interactions of Nitrogen-Containing Xenobiotics with Monoamine Oxidase (MAO) Isozymes A and B: SAR Studies on MAO Substrates and InhibitorsChemical Research in Toxicology, 2001
- Rediscovering monoamine oxidase inhibitors.BMJ, 1989
- Melatonin plasma response to MAO inhibitor: Influence on human pineal activity?Acta Psychiatrica Scandinavica, 1988
- The Fate of Melatonin in AnimalsJournal of Biological Chemistry, 1961
- [Monoamine oxidase inhibitors].1960